Convalescent Plasma to Limit SARS-CoV-2 Associated Complications (CSSC-004)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04373460 |
Recruitment Status :
Active, not recruiting
First Posted : May 4, 2020
Last Update Posted : June 7, 2022
|
Sponsor:
Johns Hopkins University
Collaborators:
State of Maryland
Bloomberg Foundation
United States Department of Defense
National Institute of Allergy and Infectious Diseases (NIAID)
National Center for Advancing Translational Science (NCATS)
Information provided by (Responsible Party):
Johns Hopkins University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Actual Primary Completion Date : | January 14, 2022 |
Estimated Study Completion Date : | September 14, 2022 |
Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):